Repros Therapeutics Inc. (RPRX) To Present Data On The Benefits Of Testosterone Restoration With Androxal® Compared To T Replacement With Gels At 9th Men's Health World Congress
11/26/2013 9:57:58 AM
THE WOODLANDS, Texas, Nov. 25, 2013 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX) today reported it will deliver an invited podium presentation at the 9th Men's Health World Congress entitled "Oral Enclomid (Androxal) Raises Total Serum Testosterone in Men with Secondary Hypogonadism: Comparison with a Topical Gel".
Help employers find you! Check out all the jobs and post your resume.
comments powered by